The Procedural Success and Complication Rate of the Left Distal Radial Approach

May 2, 2018 updated by: Seung Hwan Lee, Wonju Severance Christian Hospital

The Procedural Success and Complication Rate of the Left Distal Radial Approach for Coronary Angiography and Percutaneous Coronary Intervention. Prospective Observational Study

Left distal transradial approach (ldTRA) can be an attractive alternative route for left radial and right radial artery. Recently, Ferdinand Kiemeneij reported the feasibility and safety of the use of ldTRA. But, there is few studies focused on this issue. Therefore, the purpose of this prospective observational study is to assess the feasibility and safety of the ldTRA for CAG and PCI.

Study Overview

Detailed Description

Femoral artery has been traditionally used as a standard route for coronary angiography (CAG) and percutaneous coronary intervention (PCI). Recently, the frequency of use of transradial approach (TRA) is increasing. TRA has several advantages in terms of more comfortable feeling, immediate ambulation, less bleeding complication and decreased mortality rate compared to transfemoral approach (TFA). 2015 ESC guidelines recommend to use of radial artery in order to reduce bleeding complication and mortality. But, most operators tend to prefer right radial approach (RRA) for the access route, because they are usually right-handed and feel more comfortable in the use of right radial artery. Particularly when the patient is obese or the operator's height is short or has a herniated disc on neck or waist, the discomfort may become greater.

In other hand, left radial approach (LRA) have several advantages. Left brachial artery or subclavian artery is less tortuous than right side. The manipulation of catheter is similar with femoral approach. Also, since most patients are right-handed, compression after LRA leads to greater comfort for the patient.

In comparison to the convenience of the patient and procedure, comparative studies on clinical outcomes showed similar results for both RRA and LRA. But LRA may be more at risk for radiation. This is because the operator has to lean more toward the patient for the procedure, which can result in increased radiation exposure.

Recently, the left distal radial artery approach (ldTRA) has been introduced as an alternative to feasibility and safety while satisfying both patient and operator convenience. The left palm is positioned facing the floor at the left groin. Left distal radial artery is punctured at the level of anatomical snuffbox. Ferdinand Kiemeneij reported that CAG and PCI were successfully performed in 70 patients.

There are no nerve and vein in the anatomical snuffbox. And distal radial artery is located at superficial area. So, there may be potential advantage to reduce bleeding complication and nerve injury. Moreover, ldTRA can be an alternative method for the patient requiring arteriovenous fistula and for the patient preparing coronary artery bypass graft because there is no injury of left radial artery.

The patients have potential bleeding risk because dual antiplatelet agents (aspirin 300mg and clopidogrel 300mg) and more than 3,000 units of unfractionated heparin should be loaded for CAG and PCI. The effective hemostasis method has not yet been established after ldTRA. Therefore, it is important to establish effective hemostasis method and timing. However, like TRA, ldTRA requires a learning curve to be mastered, and it cannot be performed if the pulse is not palpable. There are few studies related to ldTRA. The purpose of this prospective observational study is to assess the feasibility and safety of the ldTRA for CAG and PCI.

Study Type

Observational

Enrollment (Actual)

200

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Gangwon-do
      • Wonju, Gangwon-do, Korea, Republic of, 26426
        • Yonsei University Wonju College of Medicine, Wonju Severance Christian Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

During 1 year, more than 200 patients who are needed to perform coronary angiography or percutaneous coronary intervention will be prospectively enrolled.

Description

Inclusion Criteria:

  • Patients over 20 years old requiring coronary angiography
  • Patients who are palpable left distal radial artery
  • Patients who agreed to participate in the study

Exclusion Criteria:

  • Patients who are not palpable left distal radial artery
  • Patients who are positive in Modified Allen's test (suspicious of occlusion of ulnar artery)
  • Pregnant women
  • Patients who are not appropriate for the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
ldTRA
Patients who are planned to perform coronary angiography will be enrolled via left distal radial artery
After puncture of left distal radial artery, coronary angiography and percutaneous coronary intervention, if needed, will be performed.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Success rate of coronary angiography
Time Frame: 1 year
The frequency of success rate of coronary angiography (%)
1 year
Success rate of percutaneous coronary intervention
Time Frame: 1 year
The frequency of success rate of percutaneous coronary intervention (%)
1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Success rate of puncture of left distal radial artery
Time Frame: 1 year
The frequency rate of successful puncture of left distal radial artery (%)
1 year
Diameter of left distal radial artery
Time Frame: 1 year
Measured by ultrasonography before procedure (mm)
1 year
Hemostasis duration at the puncture site
Time Frame: 1 year
Hemostasis duration after procedure (minute)
1 year
Complications at the puncture site
Time Frame: 1 year
The frequency rate of complications at the puncture site (%)
1 year
Procedure time
Time Frame: 1 year
Procedure time including coronary angiograph and percutaneous coronary intervention, if performed (minute)
1 year
Exposure time of radiation
Time Frame: 1 year
Total exposure time of radiation during procedure (minute)
1 year
Dose of radiation
Time Frame: 1 year
Dose of radiation during procedure (Gy-cm2)
1 year
The degree of patient's satisfaction
Time Frame: 1 year
Questionnaire using visual analogue scale for the pain and satisfaction of overall procedure especially focused on the left distal radial approach (Maximum 10 score, Minimum 0 score)
1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Seung-Hwan Lee, MD, PhD, Wonju Severance Christian Hospital, Yonsei University Wonju College of Medicine

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

October 11, 2017

Primary Completion (ACTUAL)

February 19, 2018

Study Completion (ACTUAL)

February 24, 2018

Study Registration Dates

First Submitted

September 17, 2017

First Submitted That Met QC Criteria

September 22, 2017

First Posted (ACTUAL)

September 25, 2017

Study Record Updates

Last Update Posted (ACTUAL)

May 8, 2018

Last Update Submitted That Met QC Criteria

May 2, 2018

Last Verified

May 1, 2018

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Coronary Artery Disease

Subscribe